| human | Q5 |
| P8179 | Canadiana Name Authority ID | ncf11894160 |
| P6178 | Dimensions author ID | 0707322745.72 |
| P10058 | IRIS UNIBO author ID | 43506 |
| P244 | Library of Congress authority ID | n2016187370 |
| P8189 | National Library of Israel J9U ID | 987007366894005171 |
| P496 | ORCID iD | 0000-0002-5008-5351 |
| P3829 | Publons author ID | 2578108 |
| P1053 | ResearcherID | N-9287-2013 |
| P1153 | Scopus author ID | 56228806600 |
| P214 | VIAF ID | 5943147270518435700003 |
| P10832 | WorldCat Entities ID | E39PBJgHbvfjtTFxy7cWxCQwmd |
| P27 | country of citizenship | Italy | Q38 |
| P108 | employer | University of Bologna | Q131262 |
| P734 | family name | Ambrosini | Q409677 |
| Ambrosini | Q409677 | ||
| Ambrosini | Q409677 | ||
| P735 | given name | Valentina | Q13589249 |
| Valentina | Q13589249 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q53132955 | (11)C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy. |
| Q44086596 | (18)F-FDG PET in Pediatric Lymphomas: A Comparison with Conventional Imaging |
| Q46126621 | (18)F-FDG PET/CT for the assessment of disease extension and activity in patients with sarcoidosis: results of a preliminary prospective study |
| Q53312438 | (68)Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours. |
| Q43289875 | (68)Ga-somatostatin analogues PET and (18)F-DOPA PET in medullary thyroid carcinoma |
| Q55052899 | 111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging. |
| Q35880375 | 11C-choline vs. 18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma |
| Q53091484 | 18F-FACBC compared with 11C-choline PET/CT in patients with biochemical relapse after radical prostatectomy: a prospective study in 28 patients. |
| Q56997197 | 18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma |
| Q56984038 | 18F-FDG PET/CT detects systemic involvement in sarcoidosis |
| Q53088031 | 18F-FDG PET/CT impact on testicular tumours clinical management. |
| Q53065988 | 68Ga DOTANOC PET/CT detects primary malignant insulinoma. |
| Q46107039 | 68Ga-DOTA-NOC: a new PET tracer for evaluating patients with bronchial carcinoid |
| Q38230179 | 68Ga-DOTA-peptides in the diagnosis of NET. |
| Q46662133 | 68Ga-DOTA-peptides versus 18F-DOPA PET for the assessment of NET patients |
| Q43412805 | 68Ga-DOTANOC PET/CT allows somatostatin receptor imaging in idiopathic pulmonary fibrosis: preliminary results |
| Q45247425 | 68Ga-citrate PET/CT for evaluating patients with infections of the bone: preliminary results. |
| Q37827752 | A new dimension of FDG-PET interpretation: assessment of tumor biology. |
| Q39446630 | Antitumor activity of sustained N-myc reduction in rhabdomyosarcomas and transcriptional block by antigene therapy |
| Q38461781 | Assessment of a chemically induced model of lung squamous cell carcinoma in mice by 18F-FDG small-animal PET. |
| Q53120424 | Cardiac FDG PET/CT is useful to assess the culprit lesion in nonST-segment elevation myocardial infarction (NSTEMI). |
| Q45126334 | Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours |
| Q57998575 | Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma |
| Q46050638 | Comparison of 18F-FACBC and 11C-choline PET/CT in patients with radically treated prostate cancer and biochemical relapse: preliminary results |
| Q53343316 | Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CT. |
| Q53063325 | Diagnostic accuracy of FDG PET/CT in mediastinal lymph nodes from lung cancer. |
| Q57998611 | Discordant response to chemotherapy: An unusual patternof fluoro-deoxy-d-glucose uptake in heavily pre-treated lymphoma patients |
| Q43184440 | Dual PET/CT with (18)F-DOPA and (18)F-FDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: Comparison with conventional imaging |
| Q46502415 | Early relapse in a patient with Hodgkin's disease and negative interim FDG-PET. |
| Q36143593 | Epithelial and mesenchymal tumor compartments exhibit in vivo complementary patterns of vascular perfusion and glucose metabolism. |
| Q45819756 | Evaluation of unusual neuroendocrine tumours by means of 68Ga-DOTA-NOC PET. |
| Q57998577 | Evolving paradigms for successful molecular imaging of medullary thyroid carcinoma |
| Q56974117 | FDG PET/CT in autoimmune pancreatitis |
| Q53150915 | FDG PET/CT is useful for the interim evaluation of response to therapy in patients affected by haematogenous spondylodiscitis. |
| Q40198035 | FDG small animal PET permits early detection of malignant cells in a xenograft murine model. |
| Q46647033 | Focal lung uptake of 18F-fluorodeoxyglucose (18F-FDG) without computed tomography findings. |
| Q40968694 | Gene transcript analysis blood values correlate with ⁶⁸Ga-DOTA-somatostatin analog (SSA) PET/CT imaging in neuroendocrine tumors and can define disease status. |
| Q56985644 | Incidence of increased 68Ga-DOTANOC uptake in the pancreatic head in a large series of extrapancreatic NET patients studied with sequential PET/CT |
| Q53272044 | Is there a role for ¹¹C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml? |
| Q51938846 | Is there an ideal diagnostic algorithm in solitary pulmonary nodules? |
| Q46152235 | Is ⁶⁸Ga-DOTA-NOC PET/CT indicated in patients with clinical, biochemical or radiological suspicion of neuroendocrine tumour? |
| Q43256310 | Late FDG PET normalization after radioimmunotherapy in a patient with non-Hodgkin lymphoma. |
| Q36673633 | Molecular imaging of neuroblastoma progression in TH-MYCN transgenic mice. |
| Q42227599 | Molecular imaging of pulmonary nodules |
| Q37860475 | PET/CT imaging in different types of lung cancer: an overview |
| Q38828570 | PET/CT in Neuroendocrine Tumors |
| Q38828681 | PET/CT in Neuroendocrine Tumors: Evaluation of Receptor Status and Metabolism |
| Q37783669 | PET/CT with 68Gallium-DOTA-peptides in NET: an overview |
| Q57998607 | Performance evaluation of a small animal PET scanner. Spatial resolution characterization using 18F and 11C |
| Q39258574 | Performance of FDG PET/ceCT in the evaluation of patients with lung cancer |
| Q37395381 | Positron-emission tomography in gynaecologic malignancies |
| Q42993036 | Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE. |
| Q37965121 | Radiopeptide imaging and therapy in Europe |
| Q48151234 | Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies. |
| Q36557482 | Role of 18F-FDG-PET and PET/CT imaging in thyroid cancer. |
| Q53485156 | Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours. |
| Q46094228 | Role of [18F]fluorodeoxyglucose positron emission tomography scan in the follow-up of lymphoma |
| Q37855273 | Small animal PET for the evaluation of an animal model of genital infection |
| Q37466740 | Small animal PET in oncology: the road from bench to bedside |
| Q45862395 | Standardized uptake values of (68)Ga-DOTANOC PET: a promising prognostic tool in neuroendocrine tumors |
| Q44600799 | The additional diagnostic value of contemporary evaluation of FDG PET/CT scan and contrast enhanced CT imaging both acquired by a last generation PET/CT system in oncologic patients. |
| Q46208557 | The detection of disease relapse after radical treatment for prostate cancer: is anti-3-18F-FACBC PET/CT a promising option? |
| Q38230239 | The use of gallium-68 labeled somatostatin receptors in PET/CT imaging |
| Q53134754 | The value of 18F-FDG PET/CT after autologous stem cell transplantation (ASCT) in patients affected by multiple myeloma (MM): experience with 77 patients. |
| Q53249637 | Value of FDG PET/CT in patients with treated ovarian cancer and raised CA125 serum levels. |
| Q45758695 | ¹⁸F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis. |
| Q37990397 | ⁶⁸Ga-labelled peptides for diagnosis of gastroenteropancreatic NET. |
| Category:Valentina Ambrosini | wikimedia |
Search more.